Medication and food interactions

Oral iron can interact with various medications and foods. It is important that clinicians ensure their patients are aware of these possible interactions, which have been summarised in the following table.

Oral Iron Therapy Interactions and Management

Interaction

How to manage the interaction

Iron absorption may be increased by:

chloramphenicol

systemic chloramphenicol increases serum iron concentration due to chloramphenicol-induced bone marrow toxicity; if myelosuppression occurs, monitor iron stores and decrease iron dose as needed; consider stopping chloramphenicol, seek specialist advice
Iron absorption may be decreased by:
antacids separate dosage times by as long as possible
calcium (eg, in dairy products such as milk) separate dosage times by several hours
Iron may decrease the absorption of:

oral bisphosphonates

(eg, alendronate, clodronate, etidronate, ibandronic acid, risedronate, tiludronate)

do not take iron within 2 hours of taking an oral bisphosphonate
levodopa, carbidopa separate dosage times by as long as possible
methyldopa separate dosage times by 2 hours; monitor BP and adjust methyldopa dose if necessary
penicillamine give iron at least 2 hours before penicilammine
thyroid hormones (eg, liothyronine, thyroxine) separate dosage times by 4–5 hours
Iron absorption is decreased by and iron decreases the absorption of:
oral quinolones (eg, ciprofloxacin, moxifloxacin, norfloxacin) take quinolone at least 2 hours before iron
tetracyclines (eg, doxycycline, minocycline) separate dosage times by as long as possible (at least 2 hours)

References

  1. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd, 2010. 
  2. National Prescribing Service. NPS News 70: Iron deficiency anaemia. Published 1 October 2010.